COVID-19 & CancerFreeNCI Sharpless: COVID-19 expected to increase mortality by at least 10,000 deaths from breast and colorectal cancers over 10 years June 19, 2020Vol.46 No.25By Matthew Bin Han Ong
COVID-19 & CancerFreeTrials & Tribulations As screening declines amid COVID-19, at-home stool DNA test for CRC gets high adherence in Medicare population June 12, 2020Vol.46 No.24By Paul J. Limburg
COVID-19 & CancerFreeGuest Editorial Impact of COVID-19 on Georgia’s community providers: a snapshot from Georgia NCORP June 12, 2020Vol.46 No.24By Guilherme Cantuaria
COVID-19 & CancerFree Fajgenbaum gained insight into COVID-19 while seeking treatment for Castleman disease (which he has) June 12, 2020Vol.46 No.24By Alexandria Carolan
Conversation with The Cancer LetterCOVID-19 & CancerFree BTK inhibitors improve COVID-19 outcomes by targeting upstream switch for inflammation, early data suggest June 12, 2020Vol.46 No.24By Matthew Bin Han Ong
COVID-19 & CancerFree #WhiteCoats4BlackLives aims to lead to real change in oncology“I’ve never been more hopeful in my entire life” June 12, 2020Vol.46 No.24By Alexandria Carolan
COVID-19 & CancerFreeGuest Editorial Working to end cancer in the time of COVID-19 June 12, 2020Vol.46 No.24By Peter WT Pisters
Free Here’s what cancer groups say about police brutality and health disparities June 05, 2020Vol.46 No.23
COVID-19 & CancerFreeGuest Editorial ASCO data will provide actionable insights from the COVID-19 pandemic—for every patient June 05, 2020Vol.46 No.23By Richard L. Schilsky
